Prarthna Bhardwaj

Breast Medical Oncology and APD @baystatehemeonc| Interested in hereditary/familial cancers and medical education

[Mark Lewis, MD, FASCO @marklewismd]

Woke up today to news of flying cars but am still using the fax machine at work

The future remains tantalizingly out of reach

[Nicholas Zaorsky, MD MS @NicholasZaorsky]

Pick any medical specialty other than your own. Who’s the most famous physician in it? You probably can’t name one.
Almost none of us will be known outside our field, and even those who achieve real professional fame are mostly forgotten within a few decades.
Fame is a poor reason to devote your life to medicine. The work itself matters more: caring for patients, discovering new knowledge, and teaching the next generation.

[Harold J. Burstein, MD, PhD, FASCO @DrHBurstein]

Important / sobering @JCOOP_ASCO on the business of cancer care
- Private equity or pharma-linked corps own > 20% of cancer care in many states
- global variation in drug prices are political not econ choices
- Ask your MD who they really work for!
https://t.co/lg7YyGnwbl

[Syed A. Ahmad @SyedAAhmad5]

Very thoughtful article. Academic medicine needs to figure out how to right the ship. More talent are leaving academics for private or industry opportunities. The question to ask now is, “Does prestige of academics even matter to the new generation? https://t.co/Mgu2HgVNhS

[Chirag Mehta @imchikachirag]

Nineteen seasons.

Nineteen summers.
Nineteen auctions.
Nineteen fresh squads.
Nineteen times people said, “maybe this year age catches up.”
Nineteen times bowlers made plans.
Nineteen times fans carried hope into another IPL.
And through all of it, one man remained.
Virat Kohli in red and gold.
We have seen entire IPL eras rise and disappear in front of our eyes. Legends changed teams. Captains changed cities. Generations changed. The league itself transformed from fearless cricket into data-driven cricket into power-hitting madness.
But one thing somehow stayed untouched.
A man walking out for RCB with impossible expectations on his shoulders.

And still delivering.

Not for 2 seasons.
Not for 5.
Not for a purple patch.

For nearly TWO DECADES.

People will talk about the numbers.
The thousands of runs.
The hundreds.
The chases.
The consistency.
The records.

And yes, they matter.

But statistics alone cannot explain what Virat Kohli has meant to this league.

Because numbers do not capture loyalty.
Numbers do not capture pressure.
Numbers do not capture what it means to carry the hopes of one franchise for 19 straight years in the loudest cricket tournament on earth.
Twelve different IPL seasons with 400+ runs.
Think about that for a second.
In a format designed for chaos…
in a league designed to expose weakness…
through injuries, form slumps, captaincy pressure, scrutiny, trolling, expectations and changing teammates…

he still found a way to show up.

Again.
And again.
And again.
Tonight was not just another innings.
It was another reminder.
That greatness is not only about peaks.
It is about returning.
Every single season.
Every single time people doubt.
Every single time the game evolves.
Every single time younger stars arrive.
And still being the standard.
There are players with bigger power.
Players with crazier strike rates.
Players with shorter bursts of brilliance.

But there has never been another Virat Kohli.

Because nobody has blended hunger, skill, fitness, passion, loyalty, pressure and longevity quite like this man.

For RCB fans, he is not just a player anymore.
He is memory.
He is childhood for one generation.
Adulthood for another.
And inspiration for the next.
Someday the IPL will continue without him.
RCB will continue without him.
New stars will come.
New heroes will rise.

But there will always be a silence when fans realize they once lived in an era where Virat Kohli opened the batting for RCB every summer.
And made it feel normal.

Love you @imVkohli to the moon and back.

[Prarthna Bhardwaj @prarthnavb]

Oh.

[JAMA @JAMA_current]

US nonprofit hospitals spent $7.8 billion on management consultants from 2009 to 2023, but contracts were not associated with meaningful changes in finance, operations, or quality of care. 🧵

https://t.co/QQswMYxrG8

[Vincent Rajkumar @VincentRK]

Leadership should not be mediocrity dressed up in titles.

Leadership is vision, excellence, and the ability to inspire.

Titles sometimes go to people who are compliant to those who appoint them than to those who are excellent and will challenge authority when needed. But we must always seek excellence in leadership.

[Prarthna Bhardwaj @prarthnavb]

The world may continue without you in many places. But in a few, irreplaceable corners, it simply doesn’t know how to.

A profound reminder of what’s most important in life!

[JAMA @JAMA_current]

"Medicine can have extraordinary meaning. But it cannot substitute for being present in your own life."

In #APieceofMyMind, a psychiatrist and residency program director reflects on an unexpected #LungCancer diagnosis.

https://t.co/V3Tae6P6mU

[Prarthna Bhardwaj @prarthnavb]

@AbiSivaMD @ASCO @CliffordHudis This is lovely, and inspiring to hear. Congratulations!

[Prarthna Bhardwaj @prarthnavb]

@TumorBoardTues @YAbdouMD @IntegrityCE @drteplinsky @IlanaSchlam @PTarantinoMD @royaryam @JasmineSukumar @maryam_lustberg @gandhi_shipra @hmcarthur @ncasasanta @nerealiamd @dradityabardia @SirohiBhawna @jhaveri_komal @elmayermd @KalinskyKevin #PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME 🔗 https://t.co/r70VedQQxk

🧐 In the phase 3 lidERA trial of adjuvant giredestrant (G) vs SOC ET what was shown❓

[Prarthna Bhardwaj @prarthnavb]

@TumorBoardTues @YAbdouMD @IntegrityCE @drteplinsky @IlanaSchlam @PTarantinoMD @royaryam @JasmineSukumar @maryam_lustberg @gandhi_shipra @hmcarthur @ncasasanta @nerealiamd @dradityabardia @SirohiBhawna @jhaveri_komal @elmayermd @KalinskyKevin #PostTest Q1️⃣ #TumorBoardTuesday
👉🏽#CME Eval 🔗 https://t.co/A9CsV5YaRJ
👉🏽ALL CME🔗 https://t.co/r70VedQQxk

🤔What 2L Tx would you offer a 54yo♀️w/ ESR1m HR+/HER2- mBC w/ PD on 1L CDK4/6i + AI?

[Prarthna Bhardwaj @prarthnavb]

@MPishvaian @TumorBoardTues @YAbdouMD @IntegrityCE @drteplinsky @IlanaSchlam @PTarantinoMD @royaryam @JasmineSukumar @maryam_lustberg @gandhi_shipra @hmcarthur @ncasasanta @nerealiamd @dradityabardia @SirohiBhawna @jhaveri_komal @elmayermd @KalinskyKevin Yes pre-emptive change of treatment with development of an ESR1m w/o radiologic progression. Clinical trial suggested doing it at routine mBC f/u intervals which is usually q3m

[Prarthna Bhardwaj @prarthnavb]

@TumorBoardTues @YAbdouMD @IntegrityCE @drteplinsky @IlanaSchlam @PTarantinoMD @royaryam @JasmineSukumar @maryam_lustberg @gandhi_shipra @hmcarthur @ncasasanta @nerealiamd @dradityabardia @SirohiBhawna @jhaveri_komal Any idea why the combination was not approved by the FDA in all comers or even with ESR1m?